We identified four high-impact variants in four candidate novel genes (ZBTB38, AQR, APBA1, and TXLNA) not implicated before in NDD or genetic diseases in four probands/families (Table 2; Fig. 2B–D, F). This evidence concerns the gene TXLNA and hereditary disease.